01Dec
Americas Antitrust Review 2021
Covid-19 has made 2020 into a year like no other with ‘stay at home’ orders and working from home the new normal. Nonetheless, the tech and pharma industries continued to attract immense antitrust scrutiny, with daily reports in the media and pressure from politicians to address what some perceive to be anticompetitive mergers by digital platforms and pharmaceutical companies, even while innovation in both sectors continues at breakneck speed. In this article, we discuss some of the most...
By:
Cooley LLP
Related
On July 9, 2019, the California Senate Judiciary Committee passed Assembly Bill 25 (AB 25), but only...
Read More >
The Employment Appeal Tribunal (EAT) provided useful clarity on when an act by an employee is done “...
Read More >
One of the first decisions issued by the Alberta Human Rights Tribunal in 2020 offers an important r...
Read More >
Residential Health Facility Rescinded Employment Offer When a Drug Screen Revealed an Applicant's Le...
Read More >
The rapid spread of COVID-19 has disrupted global commerce, destabilized the world’s leading econom...
Read More >
As we previously reported, Washington State has begun implementing its new Paid Family & Medical Lea...
Read More >